- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06458205
Impact of Multi-Component Interventions on High-Risk COPD Smokers (POPMIX-Smoking)
Population Medicine Multimorbidity Interventions in Xishui on High-risk COPD Smokers: A Cluster Randomized Controlled Trial
Study Participants: In our study, we focus on smokers who self-report a "current smoking" status or smoking cessation less than 6 months. This trial is a sub-trial of "Impact of Multi-Component Interventions on a High-Risk COPD population" (Protocol ID: CAMS&PUMC-IEC-2024-040). All smokers in this trial are either from the high-risk COPD population (defined by COPD-SQ score≥16) .
Intervention: For study participants in the intervention arm, we will ask them to finish an online COPD-SQ questionnaire with notification of his or her COPD high risk. For those whose score of COPD-SQ ≥ 16, we will provide a face-to-face survey, simple physical examination, pulmonary function tests, and provide a multi-component intervention at baseline. For smokers in the intervention arm, we provide a digital health intervention program, NicQuit, to whom could familiarly use intelligent mobile phones, and health education for all smokers. We also provide community-based spirometry pulmonary function test (PFT) and education to smokers. If smokers whose post-bronchodilator FEV1/FVC<0.7, they will be spirometry-defined COPD patients and will be encouraged to seek treatment and medication to the superior hospitals. Additionally, we provide (1) another digital health intervention programs to smokers with mental health issues; (2) CBT-based health education for study participants with abnormal BMI; (3) active recruitment into National Essential Public Health Program in China for those with abnormal blood pressure and blood glucose. Intensive follow-ups will be conducted at month 3 (telephone interview), month 6 (face-to-face with full steps of physical examination), and month 12.
Comparison: Those who are assigned in the control arm, we will ask them to finish the same COPD-SQ online questionnaire with notification of his or her COPD high risk status and a face-to-face survey. No physical examinations, community-based pulmonary function tests will be given.
Outcomes: The primary outcomes are self-reported average number of cigarettes consumed per day, smoking dependence index, and CO measurement.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Guizhou
-
Zunyi, Guizhou, China
- Xishui County for Xishui Trial
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 35 and above;
- High-risk COPD population defined by the score of COPD-SQ ≥ 16;
- Self-report currently smoking or smoking cessation less than 6 month;
- Local residents who stay within a township in the previous 3 months and plan to stay within the same township for the next 12 months.
Exclusion Criteria:
- Those who suffer from severe cognitive disorder or total loss of ability of daily living.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention arm
For all townships within the intervention arm, we have constructed a pay-for-population mechanism to incentivize all medical practitioners to care for population health within each township.
For smokers, we will provide a multi-component intervention: (1) NicQuit, a CBT-based digital health intervention for those who use intelligent mobile phones; (2) community-based pulmonary function test; (3) health education and encouragement to seek medication in superior hospitals for those spirometry-defined COPD patients; (4) CBT-based health education to the abnormal BMI; (5) health education to smoking cessation; (6) Active recruitment of smokers with high blood pressure or high blood glucose measurement.
Intensive follow-ups will be at month 3, 6, and 12.
|
|
|
No Intervention: Control Arm
We will notify smokers with high-risk COPD to seek further diagnoses in superior hospitals.
We provide a face-to-face survey to smokers with high-risk COPD.
No other specified interventions will be given, they will be always accessible to usual care within the study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Amount of smoking
Time Frame: 1 year
|
Definition: Average number of cigarettes smoked per day; Variable type: Continuous; Measurement: Respondent's answer to the question.
|
1 year
|
|
Smoking Dependence
Time Frame: 1 year
|
Definition: A scale that measures the degree of smoking dependence; Variable type: Continuous; Measurement: Respondent's answer to the question.
Introduction to Smoking Dependence Scale: Chinese version of Fagerström test for nicotine dependence (FTND), ranging from 0 to 10, the higher the score, the severer nicotine dependence will be.
Also Heaviness of Smoking Index (HSI) will also be measured, ranging from 0 to 6, the higher the score, the worsen the nicotine dependence will be
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FEV1 measurement
Time Frame: 1 year
|
Definition: Forced Expiratory Volume in one second (FEV1); Variable type: Continuous; Measurement: Pulmonary function test, portable spirometry;
|
1 year
|
|
COPD Screening
Time Frame: 1 year
|
Definition: Have you ever had a pulmonary function test?; Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
Self-awareness of COPD
Time Frame: 1 year
|
Definition: Have you ever been diagnosed with COPD?; Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
COPD-Knowledge
Time Frame: 1 year
|
Definition: COPD Knowledge Questionnaire; Variable type: Continuous; Measurement: Respondent's answer to the questions;
|
1 year
|
|
Treatment adherence
Time Frame: 1 year
|
Definition: Are you currently receiving a COPD treatment plan prescribed by a doctor or other healthcare professional?;
Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
COPD control
Time Frame: 1 year
|
Definition: Has the number of acute exacerbations decreased in the past six months?; Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
Blood pressure
Time Frame: 1 year
|
Definition: Systolic and diastolic blood pressure (mmHg); Variable type: Continuous; Measurement: Omron portable automatic blood pressure monitor;
|
1 year
|
|
Blood Glucose
Time Frame: 1 year
|
Definition: Reference standard for average plasma glucose concentration over a period of time; Variable type: Continuous; Measurement: Blood glucose meter;
|
1 year
|
|
Waist circumference
Time Frame: 1 year
|
Definition: Waist circumference (cm); Variable type: Continuous; Measurement: Soft measuring tape;
|
1 year
|
|
BMI
Time Frame: 1 year
|
Definition: Body mass index (BMI), weight divided by height squared (kg/m²); Variable type: Continuous; Measurement: Calculation;
|
1 year
|
|
HBP Screening
Time Frame: 1 year
|
Definition: Have you ever had your blood pressure measured by a doctor, nurse, or other healthcare professional?;
Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
HBP Diagnosis
Time Frame: 1 year
|
Definition: Have you ever been diagnosed with hypertension by a doctor?; Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
T2DM Screening
Time Frame: 1 year
|
Definition: Have you ever had your blood glucose measured by a doctor, nurse, or other healthcare professional?;
Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
T2DM Diagnosis
Time Frame: 1 year
|
Definition: Have you ever been diagnosed with T2DM by a doctor?; Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
T2DM Treatment
Time Frame: 1 year
|
Definition: Are you currently receiving a type 2 diabetes treatment plan prescribed by a doctor or other healthcare professional?;
Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
T2DM Control
Time Frame: 1 year
|
Definition: Blood glucose within the normal range at the end-of-year follow-up; Variable type: Binary; Measurement: Blood glucose measurement;
|
1 year
|
|
Smoking Status
Time Frame: 1 year
|
Definition: Do you currently smoke?; Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
Drinking Status
Time Frame: 1 year
|
Definition: Frequency of alcohol consumption in the past 3 months; Variable type: Categorical; Measurement: Respondent's answer to the question;
|
1 year
|
|
Sugar Consumption
Time Frame: 1 year
|
Definition: Frequency of consumption of sugary foods/drinks; Variable type: Categorical; Measurement: Respondent's answer to the question;
|
1 year
|
|
Salted Vegetables Consumption
Time Frame: 1 year
|
Definition: Frequency of consumption of salty vegetables; Variable type: Categorical; Measurement: Respondent's answer to the question;
|
1 year
|
|
Vegetable Consumption
Time Frame: 1 year
|
Definition: Frequency of consumption of vegetable; Variable type: Categorical; Measurement: Respondent's answer to the question;
|
1 year
|
|
HBP Control
Time Frame: 1 year
|
Definition: Blood pressure within the normal range at the end-of-year follow-up; Variable type: Binary; Measurement: Blood pressure measurement;
|
1 year
|
|
Number of Chronic Conditions Controlled
Time Frame: 1 year
|
Definition: Among 7 objectively measured health conditions (COPD, asthma, depression symptoms, anxiety symptoms, BMI, hypertension, type 2 diabetes), the number of chronic conditions controlled; Variable type: Counting data; Measurement: Through objective physical examination or validated scale;
|
1 year
|
|
HBP Treatment
Time Frame: 1 year
|
Definition: Are you currently taking any antihypertensive medication prescribed by a doctor or other healthcare professional?
; Variable type: Binary; Measurement: Respondent's answer to the question;
|
1 year
|
|
Depression Symptoms
Time Frame: 1 year
|
Definition: Emotional disorders, including sadness, loss, and anger; Variable type: Continuous; Measurement: PHQ-9; Introduction to PHQ-9: Patient Health Questionnaire- 9 items (PHQ-9), ranging from 0 to 27, the higher the score, the severer the depression symptoms for the respondents will be.
|
1 year
|
|
Anxiety Symptoms
Time Frame: 1 year
|
Definition: Unpleasant state of inner turmoil; Variable type: Continuous; Measurement: GAD-7; Introduction to GAD-7: General Anxiety Disorder - 7 (GAD-7), ranging from 0 to 21, the higher the score, the severer the anxiety symptoms for the respondents will be.
|
1 year
|
|
Warwick-Edinburgh Mental Well-being Scale, WEM -WBS
Time Frame: 1 year
|
Definition: Reflects overall mental health problems; Variable type: Continuous; Measurement: WEMWBS; Introduction to WEMWBS: Warwick-Edinburgh Mental Well-being Scale, ranging from 14 to 70, the lower the score, the worse one's general mental health will be.
|
1 year
|
|
Self-rate health status
Time Frame: 1 year
|
Definition: General self-assessed health status; Variable type: Continuous; Measurement: EQ-5D scale; Introduction to EQ-5D-5L scale: The 5-level EQ-5D version (EQ-5D-5L) was introduced by the EuroQol Group in 2009 to improve the instrument's sensitivity and to reduce ceiling effects, as compared to the EQ-5D-3L.
The scale could be transferred to health utility value, ranging from 0 to 1 continuously.
0 represents death and 1 represents perfect health.
|
1 year
|
|
Physical proof of cigarettes
Time Frame: 1 year
|
Definition: Can you show me your cigarettes?
Variable type: Binary; Measurement: Self-report questions and to let respondents show to our field workers whether he or she brings cigarettes.
|
1 year
|
|
Productivity Loss
Time Frame: 1 year
|
Definition: Productivity loss due to illness or health problems; Variable type: Continuous; Measurement: Respondent's answer to the question; Introduction to WPAI-GH : Work Productivity and Activity Impairment-General Health (v2.0) Chinese version.WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity, i.e., worse outcomes, as follows: Questions:
Scores: Multiply scores by 100 to express in percentages. Percent work time missed due to health: Q2/(Q2+Q4) Percent impairment while working due to health: Q5/10 Percent overall work impairment due to health: Q2/(Q2+Q4)+[(1-(Q2/(Q2+Q4)))x(Q5/10)] Percent activity impairment due to health: Q6/10 |
1 year
|
|
Number of Outpatient Visits
Time Frame: 1 year
|
Definition: Outpatient visits and type of hospital; Variable type: Count; Measurement: Survey/insurance/outpatient data;
|
1 year
|
|
Number of Inpatient Visits
Time Frame: 1 year
|
Definition: Inpatient visits and type of hospital; Variable type: Count; Measurement: Survey data/insurance/inpatient data;
|
1 year
|
|
Medical expenditure within a family over the past year
Time Frame: 1 year
|
Definition: Healthcare-related expenditures; Variable type: Continuous; Measurement: Survey/insurance/outpatient/inpatient data;
|
1 year
|
|
Physical exercise
Time Frame: 1 year
|
Definition: Frequency of physical exercise; Variable type: Categorical; Measurement: Respondent's answer to the question;
|
1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Simiao Chen, Ph.D., Peking Union Medical College
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAMS&PUMC-IEC-2024-042
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Reduction
-
West Virginia UniversityRecruitingSmoking Reduction | Smoking BehaviorsUnited States
-
University of California, San FranciscoTobacco Related Disease Research ProgramCompletedSmoking Cessation | Smoking Reduction | Smoking, TobaccoUnited States
-
Ghana Health ServicesKwame Nkrumah University of Science and TechnologyNot yet recruitingSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking Behaviors
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Columbia UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Smoking Reduction | Smoking BehaviorsUnited States
-
Universidad Católica San Antonio de MurciaCompleted
-
University of Kansas Medical CenterRecruiting
-
Nikki Nollen, PhD, MARecruitingSmoking ReductionUnited States
-
University of OregonOhio State UniversityCompletedSmoking Cessation | Cancer | Smoking ReductionUnited States
Clinical Trials on Multi-component intervention for smokers
-
Universidad de SantanderUniversidad Santo Tomas; Universidad Manuela Beltrán; Fundación Oftalmológica... and other collaboratorsRecruitingMild Cognitive ImpairmentColombia
-
Chiba UniversityNovo Nordisk A/S; Delivery Associates; The Behavioural Insights TeamNot yet recruitingObesity | Physical Activity | Childhood Obesity | Nutrition | Quality of Life (QOL)Japan
-
University of California, San DiegoRecruitingObesity | Diabetes | Schizophrenia | Serious Mental Illness | Lifestyle Risk ReductionUnited States
-
Peking Union Medical CollegeChina-Japan Friendship HospitalCompletedMultimorbidity | Chronic Asthma | Population MedicineChina
-
George Washington UniversityCompletedPrEP | HIV Risk PerceptionUnited States
-
University of Southern DenmarkActive, not recruitingNeck Pain | Shoulder Pain | Lifestyle
-
Fangbiao TaoNot yet recruitingEffectiveness of an AI-Enabled Mobile Intervention on Lifestyle Behaviors and Maternal-Infant HealthPrevention | Lifestyle Intervention | Mobile Health Apps | Multi-component Based Behavioral InterventionChina
-
HBSARecruitingBinge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related HarmsUnited States
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Singapore General HospitalSengkang General Hospital; Sengkang Community Hospital; Outram Community HospitalCompletedStroke | Implementation ScienceSingapore